NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Meanwhile, GSK’s (NYSE:GSK) full-year revenue grew ~7% YoY to £31.3B as specialty medicines sales jumped 19% YoY and vaccine sales fell ~4% YoY. Meanwhile, its core earnings per share for Q4 ...
GSK (GSK) plc announces the commencement of its share buyback program, as announced in its 2024 full year results announcement published on 5 February 2025. The Program will return an additional ...